The article highlights the several aspects of early rheumatoid arthritis (RA) including
classification criteria, diagnostic and predictive biomarkers, and precision medicine in RA …

Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis that affects the
adult population. Early diagnosis and treatment are the cornerstones to prevent joint …

Early treatment of rheumatoid arthritis (RA) with disease-modifying antirheumatic drugs will
improve the outcome significantly. Early diagnosis of RA continues to be a challenge. The …

Rheumatoid arthritis (RA) is an aggressive autoimmune inflammatory disease, with a highly
variable and generally unpredictable prognosis. Recent successful therapies have …

The treatment of rheumatoid arthritis (RA) has changed dramatically in the past decade as
advancements in the understanding of the pathobiology of the disease have led to novel …

The utilization and identification of biomarkers in rheumatoid arthritis (RA) to facilitate timely
diagnosis and the optimal management of the disease is an area of active investigation. This …

Multiple studies have shown that there is a pre-clinical period preceding the development of
rheumatoid arthritis (RA). During this period, complex interactions between the …

Effective treatment of rheumatoid arthritis (RA) has been hampered by the heterogeneity of
the disease. Although early intervention can result in disease remission, it requires early …

Recent emphasis on early diagnosis and treatment of rheumatoid arthritis (RA) to improve
long-term disease outcome has raised important questions about optimal therapy for early …

Understanding of early arthritis is increasing, especially in prognostic and therapeutic
respects, and new treatment strategies appear to improve the outcome in patients with early …